In This Article:
As the UK market grapples with global economic challenges, including weak trade data from China impacting major indices like the FTSE 100 and FTSE 250, investors are increasingly turning their attention to small-cap stocks that may offer untapped potential. In this environment, identifying promising companies requires a keen eye for those with robust fundamentals and resilience amidst broader market volatility.
Top 10 Undiscovered Gems With Strong Fundamentals In The United Kingdom
Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
---|---|---|---|---|
M&G Credit Income Investment Trust | NA | 17.28% | 15.80% | ★★★★★★ |
London Security | 0.22% | 10.13% | 7.75% | ★★★★★★ |
Andrews Sykes Group | NA | 2.15% | 4.93% | ★★★★★★ |
B.P. Marsh & Partners | NA | 29.42% | 31.34% | ★★★★★★ |
Impellam Group | 31.12% | -5.43% | -6.86% | ★★★★★★ |
VH Global Sustainable Energy Opportunities | NA | 18.30% | 20.03% | ★★★★★★ |
Rights and Issues Investment Trust | NA | -3.68% | -4.07% | ★★★★★★ |
FW Thorpe | 5.89% | 11.97% | 12.07% | ★★★★★☆ |
BBGI Global Infrastructure | 0.02% | 3.08% | 6.85% | ★★★★★☆ |
Goodwin | 52.21% | 9.26% | 13.12% | ★★★★★☆ |
Let's dive into some prime choices out of from the screener.
Cohort
Simply Wall St Value Rating: ★★★★★★
Overview: Cohort plc is a company that offers a range of products and services in the defense and security sectors across multiple regions including the United Kingdom, Germany, Portugal, Africa, North and South America, the Asia Pacific, and other European countries with a market cap of £417.11 million.
Operations: Revenue primarily comes from two segments: Sensors and Effectors (£120.49 million) and Communications and Intelligence (£83.38 million).
Cohort, a player in the Aerospace & Defense sector, has demonstrated solid financial health with earnings growing at 16.3% annually over the past five years. Its debt-to-equity ratio improved from 32.5% to 29.2%, indicating prudent financial management. Recently, Cohort completed a follow-on equity offering worth £40 million at £8.75 per share, suggesting strategic capital raising efforts for future growth initiatives. The company's interest payments are comfortably covered by EBIT at 17.5 times coverage, reflecting strong operational profitability and high-quality earnings that bolster investor confidence in its ongoing performance and potential value appreciation.
-
Unlock comprehensive insights into our analysis of Cohort stock in this health report.
-
Review our historical performance report to gain insights into Cohort's's past performance.
RHI Magnesita
Simply Wall St Value Rating: ★★★★★☆